Please provide your email address to receive an email when new articles are posted on . In reporting findings from the phase 2b Insulin Liver Effect (ISLE-1) trial, the researchers also found that ...
The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...
INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results